Q-Linea | QLINEA Logo | Annual Report & Investor Relations Data

Q-Linea | QLINEA Annual Report & Investor Relations Data

ISIN

SE0011527845

Ticker

QLINEA

Sector

Health Care

Industry

Health Care Equipment & Supplies

Country

Sweden

Year Founded

2007

Q-Linea (QLINEA)
Company Overview & Profile

Company Description

Q-linea develops and delivers innovative solutions for the diagnosis of infectious diseases, with a keen focus on improving sepsis treatment while reducing antibiotic resistance

Q-linea is a company that develops innovative solutions for improved infectious disease diagnostics. The company focuses on developing instruments and consumables that benefit patients, healthcare providers and society. Q-linea develops and delivers solutions for healthcare providers, enabling them to diagnose and treat infectious diseases in the shortest possible time. The company’s leading product, ASTar®, is a fully automated instrument for antimicrobial susceptibility testing, which produces a sensitivity profile from a positive blood culture within ~six hours. This is 24 to 40 hours faster than current diagnostics.

Served Area

Worldwide

Headquarters

Dag Hammarskjölds väg 52 A
75237, Uppsala
Sweden

Q-Linea (QLINEA)
Filings & Annual Reports

Filters

View all types
Type Document Details Language Filing Date File Number

Get API Access

Access comprehensive European stock market filings data through a single, powerful API.

1,5M+

filings covered

18

European countries

30min

max latency

1 API

for all filings

Q-Linea (QLINEA)
Insider Trading Activity

Date Trading entity / Person Association Trade type Volume
03.08.2023 Nexttobe AB Other Buy SEK 69,397,836.00
21.07.2023 Christer Samuelsson Other Other SEK 90,000.00
14.03.2023 Christer Samuelsson Other Buy SEK 141,731.01
13.03.2023 Christer Samuelsson Other Buy SEK 41,398.00
28.02.2023 Jonas Jarvius Other Buy SEK 437,283.00
28.02.2023 CFO Akuten AB Other Buy SEK 112,955.62
28.02.2023 Jonas Jarvius Other Buy SEK 31,505.98
28.02.2023 Jonas Jarvius Other Buy SEK 3,096.00
28.02.2023 Jonas Jarvius Other Buy SEK 52.00
28.02.2023 Jonas Jarvius Other Buy SEK 20.32

Q-Linea (QLINEA)
Leadership: Management & Supervisory Board

No Leadership Information Available

We currently don't have information about the management or supervisory board for this company. This information will be updated as soon as it becomes available.

Q-Linea (QLINEA)
Stock & Investor Information

ISIN

SE0011527845

LEI

549300BXVB4XRM8WSC73

Stock Exchange Listings

Nasdaq Stockholm

Q-Linea (QLINEA)
Related Companies & Peer Group

Achiko AG Logo

Achiko AG

ACHI

Sector

Health Care

Country

Switzerland

ISIN

CH0522213468

Founded

Achiko AG (SIX: ACHI.SW; OTCQB: ACHKF; www.achiko.com) is developing disruptive diagnostic solutions that puts people first. The company’s lead product …

Affluent Medical Logo

Affluent Medical

AFME

Sector

Health Care

Country

France

ISIN

FR0013333077

Founded

2011

ffluent Medical is committed to offering the best available therapies worldwide for hitherto largely unmet needs in terms of widespread …

Airway Medix S.A. Logo

Airway Medix S.A.

AWM

Sector

Health Care

Country

Poland

ISIN

PLAIRWY00017

Founded

2013

Airway Medix S.A. focuses on research and development work and commercialisation of innovative, disposable devices for the mechanically ventilated patients …

Alcon AG Logo

Alcon AG

ALC

Sector

Health Care

Country

Switzerland

ISIN

CH0432492467

Founded

1945

Alcon is the global leader in eye care, dedicated to helping people see brilliantly. With our 70-plus-year heritage, we are …

Ambu Logo

Ambu

AMBU

Sector

Health Care

Country

Denmark

ISIN

DK0060946788

Founded

1937

Ambu has been bringing the solutions of the future to life since 1937. Today, millions of patients and healthcare professionals …

Bactiguard Holding Logo

Bactiguard Holding

BACTI

Sector

Health Care

Country

Sweden

ISIN

SE0005878741

Founded

2005

Bactiguard is a Swedish medical device company with a mission to save lives. To achieve this mission, we develop and …